PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
Sheila K. Pirooznia(Johns Hopkins University), Ted M. Dawson(Johns Hopkins University), Yulan Xiong(University of Connecticut), Mohammed Repon Khan(Johns Hopkins University), Luan Wang(Wayne State University), Changqing Yuan(Johns Hopkins University), Senthilkumar S. Karuppagounder(Johns Hopkins University), Yunjong Lee(Sungkyunkwan University), Sung Ung Kang(Johns Hopkins University), Valina L. Dawson(Johns Hopkins University)
Cited by 87
Related Papers
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff
|Fly|2012|12.6k
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
|Molecular Neurodegeneration|2020|484